Drug Profile
Research programme: depression therapy - BioLineRx
Alternative Names: EDP 18Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BioLineRx
- Class Small molecules
- Mechanism of Action TRPV cation channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Major depressive disorder in Israel